Efforts to promote safer opioid prescribing in Canada appear to be having an effect, as new research in CMAJ (Canadian Medical Association Journal) shows a decrease in opioid dispensing between 2018 and 2022.
In the early 2000s, the use of prescription opioids to treat acute and chronic noncancer pain increased substantially in Canada, leading to a rise in opioid-related harms.
The availability of more opioid products, coupled with aggressive marketing of these drugs, contributed to these early increases in Canada and in other countries.
Research in CMAJ shows a decrease in opioid dispensing between 2018 and 2022.
Author's summary: Opioid prescribing declines in Canada.